Dechra Pharmaceuticals PLC

DCHPF · OTC
Analyze with AI
6/30/2023
12/31/2022
6/30/2022
12/31/2021
Operating Activities
Net Income-$51$23$18$41
Dep. & Amort.$41$9$36$7
Deferred Tax$46$7$57-$18
Stock-Based Comp.-$3$2$2$1
Change in WC-$44-$9-$59$16
Other Non-Cash$22$20-$19$23
Operating Cash Flow$12$52$35$88
Investing Activities
PP&E Inv.-$12-$11-$9-$11
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$6-$398-$19-$39
Investing Cash Flow-$18-$408-$29-$50
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid-$14-$37-$13-$32
Other Fin. Act.$9$359-$1-$0
Financing Cash Flow-$5$321-$14-$32
Forex Effect-$3$2$5-$1
Net Chg. in Cash-$7-$17-$1$3
Supplemental Information
Beg. Cash$0$0$0$121
End Cash-$7-$17-$1$124
Free Cash Flow-$0$41$26$77